Nifty Pharma under pressure: Is it time to square off your positions?
A few Indian pharma companies are already working in the specialty products business in the US, which is a very high-value market as against…
23 November 2021
A few Indian pharma companies are already working in the specialty products business in the US, which is a very high-value market as against…
Do we have a vaccine for HIV? No; Maleria? No; SARS/MERS? No; But we are not scared of them today. Why?